摘要
目的:了解EB病毒VCA-IgA与鼻咽癌临床表现的关系.方法:对梧州市肿瘤所门诊经病理确诊的鼻咽癌患者1868例,应用免疫酶法测定鼻咽癌病人血清中EB病毒VCA-IgA抗体.EB病毒VCA-IgA抗体测定结果与鼻咽癌患者的临床主要特征及分期进行分析.结果:EB病毒VCA-IgA抗体水平与鼻咽癌患者的性别无关;与患者各年龄组之间无显著差异;患者原发灶TO-T4其抗体水平有轻微上升,但无明显的波动;患者的临床分期Ⅰ～Ⅳ期根据病程的发展有逐渐升高的趋势;而早期(Ⅰ、Ⅱ)与晚期(Ⅲ、Ⅳ)期比较、颈部淋巴结N_0～N_3之间的比较有显著的差异.结论:结果分析提示EB病毒VCA-IgA抗体水平与鼻咽癌的发生及发展有密切关系.
Purpose: Analyzed rationship between level VCA-IgA of EBV and clinical stages in 1868 NPC patients who were diagnosised by pathology in Wuzhou Institute for cancer Res. Method:VCA-IgA detected with immunoenzyme method. Results; level of VCA-IgA did not relate with sex of NPC patients, had not differente among age groups and among TO to T4 group(pro-tocanteen ), but had obviously differente in patients between early stages ( I ,? ) and late stages ( ?, IV ). Concl usion: Result prompt there is closen relation between VCA-IgA level and NPC.
出处
《临床肿瘤学杂志》
CAS
1998年第1期30-32,共3页
Chinese Clinical Oncology
